ADD ANI AS A TRUSTED SOURCE
googleads
Menu
Business

Vivanza Biosciences Ltd reports Net Profit Jump of 37 per cent in 9MFY24; Total Income more than doubles to Rs. 23.50 crore

Ahmedabad (Gujarat) [India], February 23: Gujarat based Vivanza Biosciences Ltd (BSE - 530057) - engaged in the business of pharmaceuticals and agro trading has reported excellent financial results for the nine months ended December 2023. Company reported consolidated total income of Rs. 23.49 crore for the 9MFY24 with a 137 per cent Y-o-Y growth as compared to total income of Rs. 9.92 crore in nine months of FY23. Net profit of the company also jumped 37 per cent to Rs. 96.13 lakh during 9MFY24 as compared to net profit of Rs. 70.19 crore.

ANI Feb 23, 2024 12:38 IST googleads

Vivanza Biosciences Ltd reports Net Profit Jump of 37 per cent in 9MFY24; Total Income more than doubles to Rs. 23.50 crore

PNN
Ahmedabad (Gujarat) [India], February 23: Gujarat based Vivanza Biosciences Ltd (BSE - 530057) - engaged in the business of pharmaceuticals and agro trading has reported excellent financial results for the nine months ended December 2023. Company reported consolidated total income of Rs. 23.49 crore for the 9MFY24 with a 137 per cent Y-o-Y growth as compared to total income of Rs. 9.92 crore in nine months of FY23. Net profit of the company also jumped 37 per cent to Rs. 96.13 lakh during 9MFY24 as compared to net profit of Rs. 70.19 crore.
Company has reported strong growth over years with 3 Year CAGR of 23 per cent sales and 69 per cent in Net profits. Going forward, the company aims to fortify its position by strategically expanding its operations, bolstering manufacturing capabilities, and optimizing organizational capacities. The Company is looking at different opportunities in untapped markets and also across a value chain. Further, the Company has also set its vision in global market to supply and execute turnkey pharmaceutical units and plans for alliances with business associates in the global market
Vivanza Biosciences Limited is a specialty pharmaceutical company focused on commercializing novel and generic pharmaceuticals, offering patients better, safe and more accessible medicines. Over the last two decades, it has carved for itself, opportunities & faced challenges head on to achieve many milestones. Company offers diversified product portfolio in therapeutic areas including Diabetes, Anti Malaria, Nephrology and Cardiovascular. Company has 100 plus contract manufacturing clients and 32 plus products in pipeline. For FY23, company reported net profit of Rs. 71.6 lakh and Total income of Rs. 18.3 crore.
Earlier in March 2023, company approved stock split in the ration of 1:10. Company approved subdivision of one Equity Share having face value of Rs.10 each into 10 Equity Shares of Rs. 1 each.
The company has further taken major initiatives like strong marketing efforts, focus on cost reduction through inventory management techniques, introduction of new products and manufacturing process without compromising quality of products and retain talented employees etc.
(ADVERTORIAL DISCLAIMER: The above press release has been provided by PNN. ANI will not be responsible in any way for the content of the same)

Get the App

What to Read Next

Business

India Emerging as Stable Investment Anchor in Turbulent Global

India Emerging as Stable Investment Anchor in Turbulent Global

Mumbai (Maharashtra) [India], March 12: As military conflict in West Asia disrupts energy supplies through the Strait of Hormuz and global liquidity tightens, leading investors, policymakers and capital markets leaders gathered at IGF Mumbai 2026: Catalysing Capital to assess India's position in an increasingly fragmented global economy.

Read More
Business

Sarbabharatiya Sangeet O Sanskriti Parishad Convenes 48th Annual

Sarbabharatiya Sangeet O Sanskriti Parishad Convenes 48th Annual

Kolkata (West Bengal) [India], March 12: Sarbabharatiya Sangeet O Sanskriti Parishad officially commenced its 48th Annual Convocation yesterday, March 11, at the historic Mahajati Sadan, Kolkata. The three-day event, running from March 11 to 13, celebrates the institution's legacy of cultural service and its mission to bridge traditional heritage with a modernized future.

Read More
Business

Nandita Desai Unveils a Unique Painting Exhibition on Vintage

Nandita Desai Unveils a Unique Painting Exhibition on Vintage

New Delhi [India], March 12: There is something quietly powerful about a window... It neither confines nor escapes. It simply allows us to look, to pause, to breathe between inner and outer worlds. In The Painted Window, multi-award-winning contemporary artist Nandita Desai turns this everyday architectural element into the soul of her fifth solo exhibition, transforming vintage and handcrafted windows into luminous works of art. Running from 16th to 21st March 2026 at the Kamalnayan Bajaj Art Gallery, Nariman Point, Mumbai, the exhibition brings together 50 artworks - windows that look outward at the world, and inward at memory and quiet reflection.

Read More
Business

AdvantageClub.ai Celebrates 100 Global Women HR Leaders Driving

AdvantageClub.ai Celebrates 100 Global Women HR Leaders Driving

Gurugram (Haryana) [India], March 12: AdvantageClub.ai, a global AI-powered employee rewards, recognition and wellbeing platform, has unveiled the winners of the Most Admired Women Awards (MAW) 2026, honouring 100 outstanding women HR leaders who are driving transformation across the global workplace landscape.

Read More
Business

Kody Technolab Ltd. Launches Medigo Robot

Kody Technolab Ltd. Launches Medigo Robot

Ahmedabad (Gujarat) [India], March 12: Kody Technolab Limited today announced the launch of Medigo Robot, a health screening robot developed to enable rapid preventive health assessments and expand access to routine screening across healthcare, public, and institutional environments.

Read More
Home About Us Our Products Advertise Contact Us Terms & Condition Privacy Policy

Copyright © aninews.in | All Rights Reserved.